Clinical trial
Trial to Assess Chelation Therapy 2
NCT02733185 is registered in ClinicalTrials.gov with Mt. Sinai Medical Center, Miami as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial to Assess Chelation Therapy 2
- Lead sponsor
- Mt. Sinai Medical Center, Miami
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 1, 2016
- Completion date
- June 30, 2023
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, myocardial infarction